AVR Latest Press Releases

-- November 17, 2025 --

Anteris Technologies Presents Data from 100 DurAVR THV Patients at PCR London Valves Globe Newswire 6:00 AM

-- November 12, 2025 --

Anteris Announces Results for the Third Quarter of 2025 Globe Newswire 5:52 PM

-- November 3, 2025 --

FDA Approves Anteris's DurAVR THV Global Pivotal Trial (the "PARADIGM Trial") Globe Newswire 7:00 AM

-- October 28, 2025 --

Anteris DurAVR THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with no Valve Related Mortality at One Year Globe Newswire 6:08 PM

-- October 27, 2025 --

Anteris Technologies Announces First Patients Treated in DurAVR THV Global Pivotal Trial (the "PARADIGM Trial") Globe Newswire 5:43 PM

Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR THV to be Presented at TCT 2025 Globe Newswire 8:43 AM

-- October 15, 2025 --

Anteris Receives First European Regulatory Clearance to Commence DurAVR THV Global Pivotal Trial (the "PARADIGM Trial") Globe Newswire 9:18 AM

-- September 19, 2025 --

Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders Globe Newswire 2:30 AM

-- September 11, 2025 --

Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders Globe Newswire 8:50 AM

-- September 4, 2025 --

Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders Globe Newswire 1:42 AM

-- August 11, 2025 --

Anteris Announces Results for the Second Quarter of 2025 Globe Newswire 4:52 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software